Walmart was too late for a Nasdaq-100 spot — but these 6 stocks made the cut

Six companies will join the Nasdaq-100 later this month — but not Walmart, which switched its listing away from the New York Stock Exchange too late to qualify for a spot in the tech-heavy index.

Market Watch • 19 hours ago

Alnylam Announces Partial Repurchase of 1.00% Convertible Senior Notes Due 2027

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (“Alnylam”) (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it has entered into separate, privately negotiated repurchase agreements with certain holders of its 1.00% Convertible Senior Notes due 2027 (the “Notes”) to repurchase for cash (the “Repurchases”) approximately $34.4 million aggregate principal amount of the Notes for a total repurchase cost (including accrued and unpaid interest) of approxima.

Business Wire • Dec 11, 2025

Eight stock picks to play one of the healthiest corners of the market

The healthcare sector of the U.S. stock market as a whole is cheaply priced, which can make it attractive to investors concerned that the S&P 500 has gotten too expensive several years into a bull market.

Market Watch • Dec 11, 2025

Is Alnylam Pharmaceuticals a Millionaire Maker?

Alnylam has been a big winner for investors since its IPO in 2004. The drugmaker's future looks promising.

The Motley Fool • Dec 7, 2025

Alnylam Pharmaceuticals Announces Changes to Board of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced changes to its Board of Directors, including the departure of two directors and the appointment of a new independent director. Mike Bonney and Carolyn Bertozzi, Ph.D., who have served in key roles on Alnylam's Board, stepped down effective December 2, 2025. Mr. Bonney joined our Board in 2014 and served as Board Chair from December 2015 to August 2021 and as Ex.

Business Wire • Dec 3, 2025

CRH, Vertiv, Ares, Alnylam Could Be Added to S&P 500 Friday in Rebalancing

Those four companies, culled from a list drawn up by KBW analyst Shreyank Gandhi, are among the largest not in the index.

Barrons • Dec 1, 2025

American Century Ultra Fund Q3 2025 Contributors/Detractors And Notable Trades

Google's parent company received a relatively benign antitrust ruling that would not force Alphabet to sell its Chrome browser or Android operating system. Chipotle Mexican Grill reported mixed quarterly results as a result of tough year-over-year comparisons and an uncertain macroeconomic environment. We initiated a position in Oracle, which is highly levered to the ongoing artificial intelligence infrastructure build-out.

Seeking Alpha • Nov 30, 2025

What's Going On With Alnylam Stock On Friday?

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stock is trading higher on Friday, with no news to justify the movement.

Benzinga • Nov 28, 2025

Virtus Silvant Mid-Cap Growth Fund Q3 2025 Performance Review

The Virtus Silvant Mid-Cap Growth Fund returned +5.43% (Class INST) for the quarter, compared to the Russell Midcap Growth Index's return of +2.78%. Palantir Technologies (PLTR) and Roblox (RBLX) were among the top stock contributors. Fair Isaac Corp. (FICO) and Verisk Analytics (VRSK) were among the largest stock detractors.

Seeking Alpha • Nov 26, 2025

S&P 500 Retailer Leads Five Resilient Stocks After Nvidia-Led Market Sell-Off

The S&P 500's TJX is among the five stocks to watch showing resilience in a tough market

Investors Business Daily • Nov 22, 2025